DNA prime/viral-vectored boost multi-antigen vaccine (Orlance)

N/A

Report date: 2025/03/19 11:38:07

Base Information

Drug NameDNA prime/viral-vectored boost multi-antigen vaccine (Orlance)

Drug Alias NameDNA prime/subunit boost multi-antigen vaccine (Profectus Biosciences)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesOrlance Inc

Inactive Companies +[1] N/A

Active IndicationsInfluenza A virus infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A